Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,126 GBX | -1.38% | -1.86% | +14.47% |
11:29am | AstraZeneca Says Potential Lung Cancer Treatment Improved Overall Survival Compared With Chemotherapy | MT |
10:17am | ASTRAZENECA : JP Morgan reiterates its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.47% | 24TCr | |
+38.51% | 73TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+7.54% | 21TCr | |
-6.01% | 20TCr | |
+6.19% | 16TCr | |
+0.31% | 16TCr | |
-0.95% | 12TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Secures European Commission's Clearance for Proposed Alexion Pharmaceuticals Deal